The protective activity of ICRF-187 against doxorubicin-induced cardiotoxicity in the rat
- 1 January 1992
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 30 (1) , 58-64
- https://doi.org/10.1007/bf00686486
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Examination of the potential long-lasting protective effect of ICRF-187 against anthracycline-induced chronic cardiomyopathyCancer Treatment Reviews, 1990
- Effect of ICRF-187 pretreatment against doxorubicin-induced delayed cardiotoxicity in the ratToxicology and Applied Pharmacology, 1990
- A functional assessment of the relative cardiotoxicity of adriamycin and epirubicin in the ratRadiotherapy and Oncology, 1989
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Time- and dose-related modifications in cardiac function in rats after single intravenous doses of epirubicinRadiotherapy and Oncology, 1988
- Amelioration of adriamycin-induced cardiotoxicity in rabbits by prenylamine and vitamins A and EAmerican Heart Journal, 1986
- Oxidative destruction of DNA by the adriamycin-iron complexBiochemistry, 1984
- Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complexBiochemistry, 1982
- Metal binding by pharmaceuticals. part 2. interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192Inflammation Research, 1982
- Adriamycin-induced myocardial lesions Report of a WorkshopThe American Journal of Surgical Pathology, 1977